Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway

Figure 6

NCL induces cisplatin resistance in cervical cancer cells by the YB1-MDR1 pathway. (a) Edu proliferation assay analysis of the effect of NCL overexpression on the growth of Hela cells treated with DDP. (b) Quantification of Edu positive cell number. (c, d) The same as that in (a) and (b), but NCL overexpression cells transfected with YB1 siRNA or control siRNA. The results presented are representative of three independent experiments.

(a)

(b)

(c)

(d)